Nurix Therapeutics, Inc. (NRIX) Earnings
|
Expand Research on NRIX
| Next EPS Date | 7/9/26 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -6.9% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -6.5% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
7/9/26  |
Q226 | N/A | -$0.72 | N/A | N/A | $15.92M | N/A | N/A | N/A | ||
| 4/8/26 |
Q126 | -$0.79 | -$0.76 | -$0.03 | $6.25M | $14.25M | N/A |  | | Details | |
| 1/28/26 |
Q425 | -$0.82 | -$0.92 | +$0.10 | $13.6M | $14.28M | N/A | | | Details | |
| 10/9/25 | Q325 | -$1.03 | -$0.83 | -$0.20 | $7.89M | $16.05M | N/A | | | Details | |
| 7/10/25 |
Q225 | N/A | -$0.71 | N/A | N/A | $16.9M | N/A | N/A | N/A | ||
| 4/8/25 |
Q125 | N/A | -$0.76 | N/A | N/A | $13.55M | N/A | N/A | N/A | ||
| 1/28/25 |
Q424 | -$0.75 | -$0.68 | -$0.07 | $13.28M | $14.91M | N/A | | | Details | |
| 10/14/24 | Q324 | -$0.67 | -$0.67 | $0.00 | $12.6M | $14.98M | N/A | | | Details |
